Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019Masahito Nakano, Takuji Torimura, Hiroshi Yatsuhashi et al.|Scientific Reports|2022Cited by 43
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching AnalysisTakashi Niizeki, Yasuhito Tanaka, Takayuki Tokunaga et al.|Targeted Oncology|2022Cited by 41
Serum Mac‐2 binding protein glycosylation isomer as a biomarker of fibrosis in living donor liver transplant graftRyu Sasaki, Kazuhiko Nakao, Sadayuki Okudaira et al.|Clinical Transplantation|2020Cited by 7
Trends in Hepatocellular Carcinoma Incidences in Japan Between 1996 and 2019Masahito Nakano, Takuji Torimura, Hiroshi Yatsuhashi et al.|Research Square|2021Cited by 1